Lynch syndrome is an autosomal-dominant genetic disorder driven by germline mutations in MMR genes (such as MLH1, MSH2, MSH6, and PMS2), harboring greater cancer risk (especially for colorectal adenocarcinoma, but also for PC) through MSI [4,10,169,178,179]. This evidence concerns the gene PMS2 and cancer.